Skip to main content

A Class II Medical Device Recall for 3M Bair Hugger System

A Class II Medical Device Recall for 3M Bair Hugger System

A Class II Medical Device Recall for 3M Bair Hugger System

Introduction

While preparations are in full swing for the first bellwether trial for 3M Bair Hugger System lawsuits, scheduled to begin in April 2018, there comes a Class II Recall as categorized by the FDA for the forced air warming blankets belonging to the following lot numbers: R10359, R10360, R10361, R10362, R10363, R10364, R10365, and R10366. The recall was made by the company after design defects were noticed which would prevent the affected blankets from warming patients during surgical procedures. More than 33,000 cases (each containing 5 units), sold worldwide are expected to be returned.

This recall does involve concerns about the airflow design but seems unrelated to the 3M infection cases which are consolidated in the District of Minnesota as MDL 2666- (In Re: Bair Hugger Forced Air Warming Devices Products Liability Litigation) before United States District Judge Joan N. Ericksen.

The court documents indicate more than 4,200 Bair Hugger lawsuits are pending which are filed on behalf of plaintiffs who developed serious and debilitating deep joint infections, allegedly related to the use of 3M’s forced-air warming blankets during their hip or knee replacement surgery.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!